Cathie Wood's $22M Biotech Shuffle, Dumps One Stock for 21st Straight Session While Other Bets Pile Up
Cathie Wood's ARK dumps $18M of Twist Bioscience while buying Recursion, Veracyte and Intellia, extending its CRISPR bet to 50 sessions.
Stocks · News reference
Tempus AI Slides as Investors Weigh $1.5 Billion Personalis Acquisition
Tempus AI stock falls after a $1.5 billion Personalis deal expands its reach in the $20 billion MRD market.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Donald Trump, Cathie Wood Bet on the Same 32 Stocks – Some Might Surprise You
A look at the stocks that are owned by Cathie Wood's Ark Invest and Donald Trump.
Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets
Cathie Wood’s ARKG bought Ionis, Beam, Veracyte and Scribe Therapeutics. Here are the biotech ETFs that also hold her latest bets.
Why Is Tempus AI Stock Falling Friday?
Tempus AI stock pulled back Friday but stays firmly above key moving averages. Is the TEM rally still intact? Read more.
Cathie Wood Buys $13.4 Million of CoreWeave Stock as Jensen Huang Says ‘Strength Is Improving Every Day,’ Ark Trims Amazon and Palantir
Cathie Wood’s Ark bought CoreWeave and Rocket Lab shares and sold Amazon and Palantir shares on Thursday, Oct. 15, 2026.
Cathie Wood Buys $12.4 Million Of CoreWeave Stock As Analyst Warns Of Equity Wipeout, Ark Sells Palantir Shares
Cathie Wood’s Ark bought CoreWeave, Cerebras and Meta shares and sold Palantir shares on Wednesday, Oct. 14, 2026.